title: Favorable outcome of an acute complex regional pain syndrome with immunoglobulin infusions.
abstract: OBJECTIVE
  To emphasize that complex regional pain syndrome (CRPS), a disabling disorder with the implication of aberrant inflammation, vasomotor dysfunction, and maladaptive neuroplasticity, might be treated with a high dose of intravenous immunoglobulin infusions (IVIG).
  
  
  METHODS
  We describe a patient who presented with CRPS in the acute phase of the disease.
  
  
  RESULTS
  The CRPS developed secondary to sciatic compression in a young patient and was treated within 10 days by high-dose IVIG (2 g/kg). It resolved completely within days after infusions.
  
  
  CONCLUSIONS
  This observational study emphasizes that high-dose IVIG may be a treatment option in the acute phase of CRPS.
authors.affiliation: Nerve-Muscle Unit, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
authors.forename: Friedrich
authors.initials: F
authors.lastname: Medlin
authors.forename: Anastasia
authors.initials: A
authors.lastname: Zekeridou
authors.forename: Susanne
authors.initials: S
authors.lastname: Renaud
authors.forename: Thierry
authors.initials: T
authors.lastname: Kuntzer
mesh_terms: D020918:Complex Regional Pain Syndromes / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D055815:Young Adult
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors